Improve your writing with a 1-year Grammarly subscription for 49% off

DEALS

If you want to showcase your writing online on your own website, in your emails, or even on social networks like Facebook, Twitter and others, you can help improve your articles by using Grammarly. It goes beyond simple spell checking to offer you instant corrections for hundreds of grammar mistakes. Today, we are offering a special deal that will give you access to one year of Grammarly Premium for just $69.98. That’s a big 49 percent off its normal $139.95 price tag.

Not only will Grammarly Premium detect spelling and punctuation mistakes in your emails and online posts, it will be able to discover and alert you to grammar issues in your articles. It will also be able to catch any contextual errors in your articles, and can even suggest different words so you can improve your vocabulary. Grammarly also offers a way to check to see if your posts follow genre-specific writing styles.

Online, there are always issues with articles that do nothing but copy and paste what others have written on their own. Grammarly Premium offers a plagiarism-checking feature that scans more than 8 billion web pages to make sure your posts are truly your own. Finally, the paid service offers full explanations of any mistakes in your articles, and even offers a weekly progress report to make sure you can see the improvements in your writing.

Your one year Grammarly Premium subscription will work on Windows, Mac, Android and iOS platforms. At nearly half off its normal price tag, it’s even more of a bargain.

Comments

The Secret Science 02:The 30 Most Disturbing Human Experiments in History

Disturbing human experiments aren’t something the average person thinks too much about. Rather, the progress achieved in the last 150 years of human history is an accomplishment we’re reminded of almost daily. Achievements made in fields like biomedicine and psychology mean that we no longer need to worry about things like deadly diseases or masturbation as a form of insanity. For better or worse, we have developed more effective ways to gather information, treat skin abnormalities, and even kill each other. But what we are not constantly reminded of are the human lives that have been damaged or lost in the name of this progress. The following is a list of the 30 most disturbing human experiments in history. 30. The Tearoom Sex Study Sociologist Laud Humphreys often wondered about the men who commit impersonal sexual acts with one another in public restrooms. He wondered why “tearoom sex” — fellatio in public restrooms — led to the majority of homosexual arrests in ...

The Strange and Stranger Case of Wyndham Lathem

A Northwestern University plague researcher has been charged with a brutal murder. Here’s what we know about him. WIKIMEDIA, TONY WEBSTER O n July 27, The Chicago Tribune reported that there was an arrest warrant issued for Wyndham Lathem , a microbiologist at Northwestern University. The crime Lathem would later be charged with was brutal—26-year-old Trenton James Cornell-Duranleau, whose body was found in Lathem’s apartment, had been stabbed dozens of times. But Lathem was nowhere to be found. As events unfolded over the following days, it became clear he had fled from Chicago to California with a second suspect, 56-year-old Andrew Warren, a University of Oxford employee from the United Kingdom visiting the states. Along the way, the two men apparently made an anonymous $1,000 donation in Cornell-Duranleau’s name to the Lake Geneva Public Library and another donation for $5,610 to a Chicago health center. Lathem had also sent a video to fa...

Popular painkiller doesn’t have more heart risks than others, study claims

NEW ORLEANS — A long-awaited study on painkillers called nonsteroidal anti-inflammatory drugs, the most widely prescribed class of drugs in the world, has concluded that the three most commonly used carry a similar risk of cardiovascular complications. Yet critics say the study was too flawed to fairly compare them. Concerns about a type of NSAID called COX-2 inhibitors peaked in 2004 when the drug Vioxx was withdrawn from the market — a decision steeped in scandal because manufacturer Merck & Co had initially hidden data that would reveal the drug’s cardiovascular risks. A second COX-2 inhibitor, Pfizer Inc.’s Celebrex, was allowed to remain on the market with the condition that Pfizer conduct a study to prove that Celebrex was no worse than two older NSAIDs, naproxen and ibuprofen. The study lasted 10 years and enrolled more than 24,000 patients, but faced challenges. Doctors in European Union countries would not participate because they were worried a...

The Research

Search This Blog